INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG TRIALS The study investigated 123 metastatic ovarian ...
Study demonstrates use of Parsortix to assess PD-L1 Status of CTCs in Non-Small Cell Lung Cancer patients with a simple blood test Further evidence supporting ANGLE's decision to develop a ...
ANGLE plc STUDY USING PARSORTIX DEMONSTRATES IMPORTANCE OF BIOMARKER-INDEPENDENT CTC ISOLATION IN HEAD AND NECK CANCER EMT status of CTCs found to provide additional insight to tumour tissue biopsy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback